Parameter | HIP | IV sucrose | p-value |
---|---|---|---|
Number of patients (Randomized) | 18 | 22 | |
Age(years) | 76 (66–83) | 66 (58–76) | 0.10 |
Sex | Male −13 Female −5 | Male −12 Female −10 | 0.33 |
Race | Caucasians −16 Africans −1 Others −1 | Caucasians- 15 Africans-6 Others-1 | 0.12 |
Blood pressure (mm Hg) Systolic | 130 (122–140) | 131 (124–140) | 0.85 |
Blood pressure (mm Hg) Diastolic | 67 (62–75) | 68 (60–72) | 0.76 |
Hemoglobin(g/L) | 110.5 (104–119) | 108.5 (102–117) | 0.39 |
Serum ferritin(ug/L) | 71 (40–143) | 67 (27–100) | 0.59 |
TSAT | 17 (14–20) | 16.5 (10–20) | 0.37 |
Patients on ESA* | 7 | 6 | 1.0 |
Average ESA dose (ug/month) | 60(60–80) | 80(60–100) | 0.20 |
Serum creatinine(umol/L) | 246.5 (206–362) | 216.5 (176–351) | 0.48 |
Glomerular filtration rate(ml/min/1.73 m2) | 20.5 (12–26) | 23 (18–33) | 0.39 |
Serum albumin | 38 (35–39) | 38.5 (36–41) | 0.58 |
Intact PTH | 13.05 (6.1-20.1) | 13.3 (7.9-16.75) | 0.93 |
Serum phosphate | 1.28 (1.07-1.42) | 1.28 (1–1.54) | 0.96 |
Cause Of ESRD | Diabetes – 6 Ischemic nephropathy-3 Hypertension – 3 Unknown – 3 Others – 3 | Diabetes −9 Ischemic nephropathy-6 Hypertension – 1 Unknown – 5 Others – 1 | 0.22 |